Axxam SpA - Product Pipeline Review - 2014

Global Markets Direct
April 30, 2014
23 Pages - GMD12091
$1,500.00

Summary

Global Markets Direct’s, ‘Axxam SpA - Product Pipeline Review - 2014’, provides an overview of the Axxam SpA’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Axxam SpA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Axxam SpA including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Axxam SpA’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Axxam SpA’s pipeline products

Reasons to buy

- Evaluate Axxam SpA’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Axxam SpA in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Axxam SpA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Axxam SpA and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Axxam SpA
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Axxam SpA and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Axxam SpA Snapshot 4
Axxam SpA Overview 4
Key Information 4
Key Facts 4
Axxam SpA - Research and Development Overview 5
Key Therapeutic Areas 5
Axxam SpA - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Axxam SpA - Pipeline Products Glance 10
Axxam SpA - Early Stage Pipeline Products 10
Discovery Products/Combination Treatment Modalities 10
Axxam SpA - Drug Profiles 11
Small Molecules to Agonize CB2 Receptor for Pain 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Small Molecules to Antagonize BDKRB1 for Pain and Ophthalmic Disorders 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Small Molecules to Block Icrac Channel For Autoimmune Disorders 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Small Molecules to Block Kv1.3 for Autoimmune disorders 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Small Molecules to Block P2RX7 for CNS and Autoimmune Disorders 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Axxam SpA - Pipeline Analysis 16
Axxam SpA - Pipeline Products by Target 16
Axxam SpA - Pipeline Products by Route of Administration 17
Axxam SpA - Pipeline Products by Molecule Type 18
Axxam SpA - Pipeline Products by Mechanism of Action 19
Axxam SpA - Dormant Projects 20
Axxam SpA - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23

List of Tables
Axxam SpA, Key Information 4
Axxam SpA, Key Facts 4
Axxam SpA - Pipeline by Indication, 2014 7
Axxam SpA - Pipeline by Stage of Development, 2014 8
Axxam SpA - Monotherapy Products in Pipeline, 2014 9
Axxam SpA - Discovery, 2014 10
Axxam SpA - Pipeline by Target, 2014 16
Axxam SpA - Pipeline by Route of Administration, 2014 17
Axxam SpA - Pipeline by Molecule Type, 2014 18
Axxam SpA - Pipeline Products by Mechanism of Action, 2014 19
Axxam SpA - Dormant Developmental Projects,2014 20
Axxam SpA, Other Locations 21

List of Figures
Axxam SpA - Pipeline by Top 10 Indication, 2014 6
Axxam SpA - Pipeline by Top 10 Target, 2014 16
Axxam SpA - Pipeline Products by Top 10 Mechanism of Action, 2014 19

$1,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax